Aurinia Pharmaceuticals (NASDAQ:AUPH) Q3 2023 Earnings SKYROCKETS By 60% – What’s Their Secret To Success?
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is making waves in the pharmaceutical industry with its latest financial results for the third quarter and nine months ending on September 30, 2023. In an impressive display of financial prowess, the company reported a substantial increase in net product revenue, reaching an astonishing $40.8 million for Q3 2023, marking a … Read more